|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02607 SH PHARMA
Nominal 
11.960 -0.110 (-0.911%) | 2025/12 - Final RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | 6,154,201 | 5,827,258 | 5,231,520 | 4,743,361 | 5,061,326 |
| Net Cash from / (used in) Investing Activities | (3,982,230) | 415,980 | (2,491,873) | (12,473,124) | (6,015,576) |
| Net Cash from / (used in) Financing Activities | (5,651,768) | (1,863,930) | 231,851 | 12,138,594 | 1,565,628 |
| Increase / (Decrease) in Cash & Cash Equivalents | (3,479,797) | 4,379,307 | 2,971,498 | 4,408,831 | 611,379 |
| Cash & Cash Equivalents at beginning of period | 31,881,273 | 27,499,809 | 24,533,891 | 20,137,500 | 19,576,445 |
| Effect of Foreign Exchange Rate Changes | (3,116) | 2,157 | (5,580) | (12,440) | (50,323) |
| Others | 0 | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | 28,398,361 | 31,881,273 | 27,499,809 | 24,533,891 | 20,137,500 |
| Remarks: | Real time quote last updated: 09/04/2026 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 5,724,558 |
| %Change | 25.745% |
| EPS / (LPS) | RMB 1.540 |
| NBV Per Share (¥) | RMB 20.465 |